2
ASCP-Chemistry section Exam with accurate detailed || || || || || ||
solutions
Aldosterone is released by the adrenal cortex upon stimulation by:
|| || || || || || || || ||
A. Renin
||
B. Angiotensinogen
||
C. Angiotenisinogen I
|| ||
D. Angiotensinogen II - ✔✔D. Angiotensinogen II
|| || || || || ||
Clinical Assays for tumor markers are most important for:
|| || || || || || || ||
A. screening for the presence of cancer
|| || || || || ||
B. monitoring the course of known cancer
|| || || || || ||
C. confirming the absence of disease
|| || || || ||
D. identifying patients at risk for cancer - ✔✔B. Monitoring the course of known cancer
|| || || || || || || || || || || || || ||
Detection of which of the following substances is most useful to monitor the course of a
|| || || || || || || || || || || || || || || ||
patient with testicular cancer?
|| || ||
A. alpha-fetoprotein
||
B. carcinoembryonic antigen
|| ||
C. prolactin
||
D. testosterone - ✔✔A. alpha-fetoprotein
|| || || ||
Increased concentrations of alpha-fetoprotein (AFP) in adults are most characteristically
|| || || || || || || || || ||
associated with: ||
,2
A. hepatocellular carcinoma
|| ||
B. alcoholic cirrhosis
|| ||
C. chronic active hepatitis
|| || ||
D. multiple myeloma - ✔✔A. hepatocellular carcinoma
|| || || || || ||
Carcinoembryonic antigen (CEA) is most likely to be produced in a maignancy involving || || || || || || || || || || || || ||
the:
A. Brain
||
B. Testes
||
C. Bone
||
D. Colon - ✔✔D. Colon
|| || || ||
Which of the following is useful in the detection an management of carcinoma of the
|| || || || || || || || || || || || || || ||
prostate?
A. total prostate-specific antigen
|| || ||
B. prostatic acid phosphatase
|| || || ||
C. human chorionic gonadotropin
|| || ||
D. alpha-fetoprotein - ✔✔A. total prostate-specific antigen
|| || || || || ||
Which of the following statements most correctly describes the utility of clinical laboratory
|| || || || || || || || || || || || ||
assays for tumor markers?
|| || ||
A. tumor markers are useful to screen asymptomatic patients for tumors
|| || || || || || || || || ||
B. tumor markers are highly specific
|| || || || ||
, 2
C. tumor markers indicate the likelihood of an individual developing a tumor
|| || || || || || || || || || ||
D. tumors are useful in tracking the efficacy of treatment - ✔✔D. tumors are useful in
|| || || || || || || || || || || || || || || ||
tracking the efficacy of treatment|| || || ||
Cancer antigen 125 (CA 125) is a tumor marker associated with:
|| || || || || || || || || ||
A. breast carcinoma
|| ||
B. colon cancer
|| ||
C. lung cancer
|| ||
D. ovarian and endometrial carcinoma - ✔✔D. ovarian and endometrial carcinoma
|| || || || || || || || || ||
In addition to carcinoma of the prostate, elevated prostate-specific antigen (PSA) can occur
|| || || || || || || || || || || || ||
due to: ||
A. aspirin therapy
|| ||
B. exogenous steroid use
|| || ||
C. benign prostatic hyperplasia
|| || ||
D. statin therapy (cholesterol lowering drugs) - ✔✔C. benign prostatic hyperplasia
|| || || || || || || || || ||
A drug has a half-life of 6 hours. If a dose is given every 6 hours, a steady-state drug level
|| || || || || || || || || || || || || || || || || || || ||
would usually be achieved in:
|| || || ||
A. 3-5 hours
|| ||
B. 10-12 hours
|| ||
C. 24-42 hours
|| ||
D. 48-50 hours - ✔✔C. 24-42 hours
|| || || || || ||
ASCP-Chemistry section Exam with accurate detailed || || || || || ||
solutions
Aldosterone is released by the adrenal cortex upon stimulation by:
|| || || || || || || || ||
A. Renin
||
B. Angiotensinogen
||
C. Angiotenisinogen I
|| ||
D. Angiotensinogen II - ✔✔D. Angiotensinogen II
|| || || || || ||
Clinical Assays for tumor markers are most important for:
|| || || || || || || ||
A. screening for the presence of cancer
|| || || || || ||
B. monitoring the course of known cancer
|| || || || || ||
C. confirming the absence of disease
|| || || || ||
D. identifying patients at risk for cancer - ✔✔B. Monitoring the course of known cancer
|| || || || || || || || || || || || || ||
Detection of which of the following substances is most useful to monitor the course of a
|| || || || || || || || || || || || || || || ||
patient with testicular cancer?
|| || ||
A. alpha-fetoprotein
||
B. carcinoembryonic antigen
|| ||
C. prolactin
||
D. testosterone - ✔✔A. alpha-fetoprotein
|| || || ||
Increased concentrations of alpha-fetoprotein (AFP) in adults are most characteristically
|| || || || || || || || || ||
associated with: ||
,2
A. hepatocellular carcinoma
|| ||
B. alcoholic cirrhosis
|| ||
C. chronic active hepatitis
|| || ||
D. multiple myeloma - ✔✔A. hepatocellular carcinoma
|| || || || || ||
Carcinoembryonic antigen (CEA) is most likely to be produced in a maignancy involving || || || || || || || || || || || || ||
the:
A. Brain
||
B. Testes
||
C. Bone
||
D. Colon - ✔✔D. Colon
|| || || ||
Which of the following is useful in the detection an management of carcinoma of the
|| || || || || || || || || || || || || || ||
prostate?
A. total prostate-specific antigen
|| || ||
B. prostatic acid phosphatase
|| || || ||
C. human chorionic gonadotropin
|| || ||
D. alpha-fetoprotein - ✔✔A. total prostate-specific antigen
|| || || || || ||
Which of the following statements most correctly describes the utility of clinical laboratory
|| || || || || || || || || || || || ||
assays for tumor markers?
|| || ||
A. tumor markers are useful to screen asymptomatic patients for tumors
|| || || || || || || || || ||
B. tumor markers are highly specific
|| || || || ||
, 2
C. tumor markers indicate the likelihood of an individual developing a tumor
|| || || || || || || || || || ||
D. tumors are useful in tracking the efficacy of treatment - ✔✔D. tumors are useful in
|| || || || || || || || || || || || || || || ||
tracking the efficacy of treatment|| || || ||
Cancer antigen 125 (CA 125) is a tumor marker associated with:
|| || || || || || || || || ||
A. breast carcinoma
|| ||
B. colon cancer
|| ||
C. lung cancer
|| ||
D. ovarian and endometrial carcinoma - ✔✔D. ovarian and endometrial carcinoma
|| || || || || || || || || ||
In addition to carcinoma of the prostate, elevated prostate-specific antigen (PSA) can occur
|| || || || || || || || || || || || ||
due to: ||
A. aspirin therapy
|| ||
B. exogenous steroid use
|| || ||
C. benign prostatic hyperplasia
|| || ||
D. statin therapy (cholesterol lowering drugs) - ✔✔C. benign prostatic hyperplasia
|| || || || || || || || || ||
A drug has a half-life of 6 hours. If a dose is given every 6 hours, a steady-state drug level
|| || || || || || || || || || || || || || || || || || || ||
would usually be achieved in:
|| || || ||
A. 3-5 hours
|| ||
B. 10-12 hours
|| ||
C. 24-42 hours
|| ||
D. 48-50 hours - ✔✔C. 24-42 hours
|| || || || || ||
